Page last updated: 2024-09-05

solifenacin succinate and Alzheimer Disease

solifenacin succinate has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chase, TN; Clarence-Smith, K; Farlow, MR	1

Trials

1 trial(s) available for solifenacin succinate and Alzheimer Disease

Article	Year
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2017, Volume: 14, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Male; Maximum Tolerated Dose; Middle Aged; Muscarinic Antagonists; Piperidines; Single-Blind Method; Solifenacin Succinate; Treatment Outcome	2017

Article

Year

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2017, Volume: 14, Issue:2

Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Male; Maximum Tolerated Dose; Middle Aged; Muscarinic Antagonists; Piperidines; Single-Blind Method; Solifenacin Succinate; Treatment Outcome

2017